 
| IPAD-DB ID | S00077 | 
| Name | Ethyl 5-amino-4-(2-chloroquinolin-3-yl)-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrano [2, 3-b]quinoline-3-carboxylate | 
| Category | Synthetic compounds | 
| 2D Structure |  | 
| 3D Structure | |
| Molecular Formula | C 2 5 H 2 4 C l N 3 O 3 | 
| Molecular Weight | 449.9 g/mol | 
| IUPAC Name | ethyl 5-amino-4-(2-chloroquinolin-3-yl)-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrano[2, 3-b]quinoline-3-carboxylate | 
| InChI | InChI=1S/C25H24ClN3O3/c1-3-31-25(30)19-13(2)32-24-21(22(27)15-9-5-7-11-18(15)29-24)20(19)16-12-14-8-4-6-10-17(14)28-23(16)26/h4, 6, 8, 10, 12, 20H, 3, 5, 7, 9, 11H2, 1-2H3, (H2, 27, 29) | 
| InChIKey | VMVWKSQMAJRJAT-UHFFFAOYSA-N | 
| Canonical SMILES | CCOC(=O)C1=C(OC2=NC3=C(CCCC3)C(=C2C1C4=CC5=CC=CC=C5N=C4Cl)N)C | 
| PubChem CID | 127052674 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | - | 
| Molecular Weight(Computed by SwissADME) | 449.93 | 
| Hac(Computed by SwissADME) | 32 | 
| Volume(Computed by ADMETlab 2.0) | 446.381 | 
| Density(Computed by ADMETlab 2.0) | 1.006 | 
| nRing(Computed by ADMETlab 2.0) | 5 | 
| MaxRing(Computed by ADMETlab 2.0) | 14 | 
| nHet(Computed by ADMETlab 2.0) | 7 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 29 | 
| Flexibility(Computed by ADMETlab 2.0) | 0.138 | 
| Stero Centers(Computed by ADMETlab 2.0) | 1 | 
| LogS(Computed by ADMETlab 2.0) | -3.537 | 
| LogD(Computed by ADMETlab 2.0) | 4.151 | 
| logP(Computed by ADMETlab 2.0) | 5.319 | 
| TPSA(Computed by SwissADME) | 87.33 | 
| Hbond Acceptor(Computed by SwissADME) | 5 | 
| Hbond Donor(Computed by SwissADME) | 1 | 
| Rotatable Bonds(Computed by SwissADME) | 4 | 
| GI Absorption(Computed by SwissADME) | High | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | Yes | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | Yes | 
| CYP2C9 Inhibitor(Computed by SwissADME) | Yes | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | Yes | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -5.4 | 
| Lipinski(Computed by SwissADME) | 0 | 
| Ghose(Computed by SwissADME) | 0 | 
| Veber(Computed by SwissADME) | 0 | 
| Egan(Computed by SwissADME) | 0 | 
| Muegge(Computed by SwissADME) | 1 | 
| Bioavailability Score(Computed by SwissADME) | 0.56 |